S

ST Pharm Co Ltd
KOSDAQ:237690

Watchlist Manager
ST Pharm Co Ltd
KOSDAQ:237690
Watchlist
Price: 94 900 KRW 0.74% Market Closed
Market Cap: 1.9T KRW
Have any thoughts about
ST Pharm Co Ltd?
Write Note

ST Pharm Co Ltd
Research & Development

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

ST Pharm Co Ltd
Research & Development Peer Comparison

Comparables:
207940
F
220100
L
141080
C
268600
E
456070

Competitive Research & Development Analysis
Latest Figures & CAGR of Competitors

Company Research & Development CAGR 3Y CAGR 5Y CAGR 10Y
S
ST Pharm Co Ltd
KOSDAQ:237690
Research & Development
-â‚©21.9B
CAGR 3-Years
-19%
CAGR 5-Years
-18%
CAGR 10-Years
N/A
Samsung Biologics Co Ltd
KRX:207940
Research & Development
-â‚©94.7B
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
F
FutureChem Co Ltd
KOSDAQ:220100
Research & Development
-â‚©2.8B
CAGR 3-Years
7%
CAGR 5-Years
-31%
CAGR 10-Years
N/A
L
LegoChem Biosciences Inc
KOSDAQ:141080
Research & Development
-â‚©87.6B
CAGR 3-Years
-6%
CAGR 5-Years
-39%
CAGR 10-Years
N/A
C
Cellivery Therapeutics Inc
KOSDAQ:268600
Research & Development
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
E
ENCell Co Ltd
KOSDAQ:456070
Research & Development
-â‚©5.5B
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is ST Pharm Co Ltd's Research & Development?
Research & Development
-21.9B KRW

Based on the financial report for Jun 30, 2024, ST Pharm Co Ltd's Research & Development amounts to -21.9B KRW.

What is ST Pharm Co Ltd's Research & Development growth rate?
Research & Development CAGR 5Y
-18%

Over the last year, the Research & Development growth was 26%. The average annual Research & Development growth rates for ST Pharm Co Ltd have been -19% over the past three years , -18% over the past five years .

Back to Top